DCTH | Delcath Systems, Inc.
Delcath Systems, Inc. (NASDAQ-DCTH) is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Our investigational product ? HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) ? is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.. MORE
About the Company
Delcath Systems, Inc. Delcath Systems, Inc. is a publicly-traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body.
Key Persons / Board of Directors
If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
Buy on Amazon
While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.